Prognostic value of ALBI score for all-cause mortality in metabolic associated fatty liver disease patients: a cohort study from NHANES 2003–2018 Article Swipe
YOU?
·
· 2025
· Open Access
·
· DOI: https://doi.org/10.1186/s12876-025-04117-1
Background & aims Metabolic Associated Fatty Liver Disease (MAFLD) is a prevalent chronic liver disorder with severe potential outcomes. While the albumin-bilirubin (ALBI) score demonstrates prognostic utility in other chronic liver diseases, its specific role and predictive performance in MAFLD patients, particularly regarding all-cause mortality, remain incompletely understood. This study aims to investigate the association between ALBI scores and all-cause mortality in individuals with MAFLD and to evaluate its prognostic potential using large-scale NHANES data. Methods Drawing on data from the population-based National Health and Nutrition Examination Survey (NHANES) conducted between 2003 and 2018, we employed weighted multivariable Cox proportional hazards regression to assess the relationship between ALBI scores and all-cause mortality in a cohort of 5,666 MAFLD patients. ALBI scores were calculated and categorized into tertile (Q1: ALBI < -2.96; -2.96 ≤ ALBI < -2.70; Q3: ≥ -2.70). MAFLD was diagnosed using the U.S. Fatty Liver Index (US-FLI) with a cutoff score of ≥ 30, while excluding other chronic liver diseases. Statistical analyses incorporated NHANES sampling weights and adjusted for potential confounders using multivariable Cox regression models. Additionally, we conducted threshold effect analysis to identify potential inflection points in the ALBI-mortality relationship and used Kaplan-Meier survival analysis to visualize survival differences across ALBI tertiles. Results In this cohort study of 5,666 MAFLD patients, 1,093 (19.29%) experienced mortality during a median follow-up of 8.5 years. Following adjustment for confounding factors, elevated ALBI scores demonstrated a significant correlation with an increased risk of death from any cause (p < 0.001). The hazard ratios (HR) for mortality across ALBI tertile (Q1-Q3) were 1.00 (reference), 1.32 (1.05–1.65), and 1.74 (1.42–2.12), respectively. Each 1-unit increase in ALBI score was associated with a 193% higher risk of death (HR: 2.93, 95% CI: 2.02–4.24). Threshold effect analysis identified an inflection point at ALBI = -2.69, using piecewise Cox regression, mortality risk increased sharply above this threshold (HR = 4.86, 95% CI: 3.32–7.11, p < 0.0001). ROC curve analysis showed AUC values of 0.715, 0.646, and 0.652 for 1-, 2-, and 3-year mortality, respectively, with calibration curves indicating strong agreement between predicted and actual probabilities. Conclusion Our study demonstrates that ALBI scores are a moderate predictor of all-cause mortality in MAFLD patients, particularly at ALBI ≥ -2.69, with an AUC of 0.715 for 1-year mortality. These findings highlight the potential of ALBI scores to identify high-risk patients early, supporting their use in clinical prognostic assessments. Future research should validate these results in diverse populations.
Related Topics
- Type
- article
- Language
- en
- Landing Page
- https://doi.org/10.1186/s12876-025-04117-1
- https://bmcgastroenterol.biomedcentral.com/counter/pdf/10.1186/s12876-025-04117-1
- OA Status
- gold
- References
- 34
- Related Works
- 10
- OpenAlex ID
- https://openalex.org/W4413035982
Raw OpenAlex JSON
- OpenAlex ID
-
https://openalex.org/W4413035982Canonical identifier for this work in OpenAlex
- DOI
-
https://doi.org/10.1186/s12876-025-04117-1Digital Object Identifier
- Title
-
Prognostic value of ALBI score for all-cause mortality in metabolic associated fatty liver disease patients: a cohort study from NHANES 2003–2018Work title
- Type
-
articleOpenAlex work type
- Language
-
enPrimary language
- Publication year
-
2025Year of publication
- Publication date
-
2025-08-07Full publication date if available
- Authors
-
Guoxing Zhou, W Han, J.J. Luan, Boyang MaList of authors in order
- Landing page
-
https://doi.org/10.1186/s12876-025-04117-1Publisher landing page
- PDF URL
-
https://bmcgastroenterol.biomedcentral.com/counter/pdf/10.1186/s12876-025-04117-1Direct link to full text PDF
- Open access
-
YesWhether a free full text is available
- OA status
-
goldOpen access status per OpenAlex
- OA URL
-
https://bmcgastroenterol.biomedcentral.com/counter/pdf/10.1186/s12876-025-04117-1Direct OA link when available
- Concepts
-
Medicine, Hepatology, Internal medicine, Cohort, Fatty liver, Disease, Cohort study, Metabolic syndrome, Gastroenterology, ObesityTop concepts (fields/topics) attached by OpenAlex
- Cited by
-
0Total citation count in OpenAlex
- References (count)
-
34Number of works referenced by this work
- Related works (count)
-
10Other works algorithmically related by OpenAlex
Full payload
| id | https://openalex.org/W4413035982 |
|---|---|
| doi | https://doi.org/10.1186/s12876-025-04117-1 |
| ids.doi | https://doi.org/10.1186/s12876-025-04117-1 |
| ids.pmid | https://pubmed.ncbi.nlm.nih.gov/40775283 |
| ids.openalex | https://openalex.org/W4413035982 |
| fwci | 0.0 |
| type | article |
| title | Prognostic value of ALBI score for all-cause mortality in metabolic associated fatty liver disease patients: a cohort study from NHANES 2003–2018 |
| biblio.issue | 1 |
| biblio.volume | 25 |
| biblio.last_page | 561 |
| biblio.first_page | 561 |
| topics[0].id | https://openalex.org/T10351 |
| topics[0].field.id | https://openalex.org/fields/27 |
| topics[0].field.display_name | Medicine |
| topics[0].score | 1.0 |
| topics[0].domain.id | https://openalex.org/domains/4 |
| topics[0].domain.display_name | Health Sciences |
| topics[0].subfield.id | https://openalex.org/subfields/2713 |
| topics[0].subfield.display_name | Epidemiology |
| topics[0].display_name | Liver Disease Diagnosis and Treatment |
| topics[1].id | https://openalex.org/T10337 |
| topics[1].field.id | https://openalex.org/fields/27 |
| topics[1].field.display_name | Medicine |
| topics[1].score | 0.9986000061035156 |
| topics[1].domain.id | https://openalex.org/domains/4 |
| topics[1].domain.display_name | Health Sciences |
| topics[1].subfield.id | https://openalex.org/subfields/2721 |
| topics[1].subfield.display_name | Hepatology |
| topics[1].display_name | Liver Disease and Transplantation |
| topics[2].id | https://openalex.org/T10760 |
| topics[2].field.id | https://openalex.org/fields/27 |
| topics[2].field.display_name | Medicine |
| topics[2].score | 0.9940999746322632 |
| topics[2].domain.id | https://openalex.org/domains/4 |
| topics[2].domain.display_name | Health Sciences |
| topics[2].subfield.id | https://openalex.org/subfields/2746 |
| topics[2].subfield.display_name | Surgery |
| topics[2].display_name | Pancreatitis Pathology and Treatment |
| is_xpac | False |
| apc_list.value | 1690 |
| apc_list.currency | GBP |
| apc_list.value_usd | 2072 |
| apc_paid.value | 1690 |
| apc_paid.currency | GBP |
| apc_paid.value_usd | 2072 |
| concepts[0].id | https://openalex.org/C71924100 |
| concepts[0].level | 0 |
| concepts[0].score | 0.9559831619262695 |
| concepts[0].wikidata | https://www.wikidata.org/wiki/Q11190 |
| concepts[0].display_name | Medicine |
| concepts[1].id | https://openalex.org/C41260117 |
| concepts[1].level | 2 |
| concepts[1].score | 0.8370771408081055 |
| concepts[1].wikidata | https://www.wikidata.org/wiki/Q668064 |
| concepts[1].display_name | Hepatology |
| concepts[2].id | https://openalex.org/C126322002 |
| concepts[2].level | 1 |
| concepts[2].score | 0.7483199834823608 |
| concepts[2].wikidata | https://www.wikidata.org/wiki/Q11180 |
| concepts[2].display_name | Internal medicine |
| concepts[3].id | https://openalex.org/C72563966 |
| concepts[3].level | 2 |
| concepts[3].score | 0.6109980344772339 |
| concepts[3].wikidata | https://www.wikidata.org/wiki/Q1303415 |
| concepts[3].display_name | Cohort |
| concepts[4].id | https://openalex.org/C2778772119 |
| concepts[4].level | 3 |
| concepts[4].score | 0.5791440010070801 |
| concepts[4].wikidata | https://www.wikidata.org/wiki/Q6058862 |
| concepts[4].display_name | Fatty liver |
| concepts[5].id | https://openalex.org/C2779134260 |
| concepts[5].level | 2 |
| concepts[5].score | 0.559285581111908 |
| concepts[5].wikidata | https://www.wikidata.org/wiki/Q12136 |
| concepts[5].display_name | Disease |
| concepts[6].id | https://openalex.org/C201903717 |
| concepts[6].level | 2 |
| concepts[6].score | 0.47795867919921875 |
| concepts[6].wikidata | https://www.wikidata.org/wiki/Q1778788 |
| concepts[6].display_name | Cohort study |
| concepts[7].id | https://openalex.org/C2780578515 |
| concepts[7].level | 3 |
| concepts[7].score | 0.42119306325912476 |
| concepts[7].wikidata | https://www.wikidata.org/wiki/Q657193 |
| concepts[7].display_name | Metabolic syndrome |
| concepts[8].id | https://openalex.org/C90924648 |
| concepts[8].level | 1 |
| concepts[8].score | 0.41421374678611755 |
| concepts[8].wikidata | https://www.wikidata.org/wiki/Q120569 |
| concepts[8].display_name | Gastroenterology |
| concepts[9].id | https://openalex.org/C511355011 |
| concepts[9].level | 2 |
| concepts[9].score | 0.13483384251594543 |
| concepts[9].wikidata | https://www.wikidata.org/wiki/Q12174 |
| concepts[9].display_name | Obesity |
| keywords[0].id | https://openalex.org/keywords/medicine |
| keywords[0].score | 0.9559831619262695 |
| keywords[0].display_name | Medicine |
| keywords[1].id | https://openalex.org/keywords/hepatology |
| keywords[1].score | 0.8370771408081055 |
| keywords[1].display_name | Hepatology |
| keywords[2].id | https://openalex.org/keywords/internal-medicine |
| keywords[2].score | 0.7483199834823608 |
| keywords[2].display_name | Internal medicine |
| keywords[3].id | https://openalex.org/keywords/cohort |
| keywords[3].score | 0.6109980344772339 |
| keywords[3].display_name | Cohort |
| keywords[4].id | https://openalex.org/keywords/fatty-liver |
| keywords[4].score | 0.5791440010070801 |
| keywords[4].display_name | Fatty liver |
| keywords[5].id | https://openalex.org/keywords/disease |
| keywords[5].score | 0.559285581111908 |
| keywords[5].display_name | Disease |
| keywords[6].id | https://openalex.org/keywords/cohort-study |
| keywords[6].score | 0.47795867919921875 |
| keywords[6].display_name | Cohort study |
| keywords[7].id | https://openalex.org/keywords/metabolic-syndrome |
| keywords[7].score | 0.42119306325912476 |
| keywords[7].display_name | Metabolic syndrome |
| keywords[8].id | https://openalex.org/keywords/gastroenterology |
| keywords[8].score | 0.41421374678611755 |
| keywords[8].display_name | Gastroenterology |
| keywords[9].id | https://openalex.org/keywords/obesity |
| keywords[9].score | 0.13483384251594543 |
| keywords[9].display_name | Obesity |
| language | en |
| locations[0].id | doi:10.1186/s12876-025-04117-1 |
| locations[0].is_oa | True |
| locations[0].source.id | https://openalex.org/S180811554 |
| locations[0].source.issn | 1471-230X |
| locations[0].source.type | journal |
| locations[0].source.is_oa | True |
| locations[0].source.issn_l | 1471-230X |
| locations[0].source.is_core | True |
| locations[0].source.is_in_doaj | True |
| locations[0].source.display_name | BMC Gastroenterology |
| locations[0].source.host_organization | https://openalex.org/P4310320256 |
| locations[0].source.host_organization_name | BioMed Central |
| locations[0].source.host_organization_lineage | https://openalex.org/P4310320256 |
| locations[0].license | cc-by-nc-nd |
| locations[0].pdf_url | https://bmcgastroenterol.biomedcentral.com/counter/pdf/10.1186/s12876-025-04117-1 |
| locations[0].version | publishedVersion |
| locations[0].raw_type | journal-article |
| locations[0].license_id | https://openalex.org/licenses/cc-by-nc-nd |
| locations[0].is_accepted | True |
| locations[0].is_published | True |
| locations[0].raw_source_name | BMC Gastroenterology |
| locations[0].landing_page_url | https://doi.org/10.1186/s12876-025-04117-1 |
| locations[1].id | pmid:40775283 |
| locations[1].is_oa | False |
| locations[1].source.id | https://openalex.org/S4306525036 |
| locations[1].source.issn | |
| locations[1].source.type | repository |
| locations[1].source.is_oa | False |
| locations[1].source.issn_l | |
| locations[1].source.is_core | False |
| locations[1].source.is_in_doaj | False |
| locations[1].source.display_name | PubMed |
| locations[1].source.host_organization | https://openalex.org/I1299303238 |
| locations[1].source.host_organization_name | National Institutes of Health |
| locations[1].source.host_organization_lineage | https://openalex.org/I1299303238 |
| locations[1].license | |
| locations[1].pdf_url | |
| locations[1].version | publishedVersion |
| locations[1].raw_type | |
| locations[1].license_id | |
| locations[1].is_accepted | True |
| locations[1].is_published | True |
| locations[1].raw_source_name | BMC gastroenterology |
| locations[1].landing_page_url | https://pubmed.ncbi.nlm.nih.gov/40775283 |
| locations[2].id | pmh:oai:doaj.org/article:6a37ae599607425aafb61f970e65a8f5 |
| locations[2].is_oa | False |
| locations[2].source.id | https://openalex.org/S4306401280 |
| locations[2].source.issn | |
| locations[2].source.type | repository |
| locations[2].source.is_oa | False |
| locations[2].source.issn_l | |
| locations[2].source.is_core | False |
| locations[2].source.is_in_doaj | False |
| locations[2].source.display_name | DOAJ (DOAJ: Directory of Open Access Journals) |
| locations[2].source.host_organization | |
| locations[2].source.host_organization_name | |
| locations[2].source.host_organization_lineage | |
| locations[2].license | |
| locations[2].pdf_url | |
| locations[2].version | submittedVersion |
| locations[2].raw_type | article |
| locations[2].license_id | |
| locations[2].is_accepted | False |
| locations[2].is_published | False |
| locations[2].raw_source_name | BMC Gastroenterology, Vol 25, Iss 1, Pp 1-12 (2025) |
| locations[2].landing_page_url | https://doaj.org/article/6a37ae599607425aafb61f970e65a8f5 |
| locations[3].id | pmh:oai:pubmedcentral.nih.gov:12329915 |
| locations[3].is_oa | True |
| locations[3].source.id | https://openalex.org/S2764455111 |
| locations[3].source.issn | |
| locations[3].source.type | repository |
| locations[3].source.is_oa | False |
| locations[3].source.issn_l | |
| locations[3].source.is_core | False |
| locations[3].source.is_in_doaj | False |
| locations[3].source.display_name | PubMed Central |
| locations[3].source.host_organization | https://openalex.org/I1299303238 |
| locations[3].source.host_organization_name | National Institutes of Health |
| locations[3].source.host_organization_lineage | https://openalex.org/I1299303238 |
| locations[3].license | other-oa |
| locations[3].pdf_url | |
| locations[3].version | submittedVersion |
| locations[3].raw_type | Text |
| locations[3].license_id | https://openalex.org/licenses/other-oa |
| locations[3].is_accepted | False |
| locations[3].is_published | False |
| locations[3].raw_source_name | BMC Gastroenterol |
| locations[3].landing_page_url | https://www.ncbi.nlm.nih.gov/pmc/articles/12329915 |
| indexed_in | crossref, doaj, pubmed |
| authorships[0].author.id | https://openalex.org/A5112552889 |
| authorships[0].author.orcid | |
| authorships[0].author.display_name | Guoxing Zhou |
| authorships[0].countries | CN |
| authorships[0].affiliations[0].institution_ids | https://openalex.org/I4210102855 |
| authorships[0].affiliations[0].raw_affiliation_string | First Affiliated Hospital, Heilongjiang University of Chinese Medicine, Harbin, 150000, Heilongjiang, China. |
| authorships[0].institutions[0].id | https://openalex.org/I4210102855 |
| authorships[0].institutions[0].ror | https://ror.org/01c0exk17 |
| authorships[0].institutions[0].type | healthcare |
| authorships[0].institutions[0].lineage | https://openalex.org/I4210102855 |
| authorships[0].institutions[0].country_code | CN |
| authorships[0].institutions[0].display_name | First Affiliated Hospital of Heilongjiang University of Chinese Medicine |
| authorships[0].author_position | first |
| authorships[0].raw_author_name | Guoxing Zhou |
| authorships[0].is_corresponding | False |
| authorships[0].raw_affiliation_strings | First Affiliated Hospital, Heilongjiang University of Chinese Medicine, Harbin, 150000, Heilongjiang, China. |
| authorships[1].author.id | https://openalex.org/A5107848603 |
| authorships[1].author.orcid | |
| authorships[1].author.display_name | W Han |
| authorships[1].countries | CN |
| authorships[1].affiliations[0].institution_ids | https://openalex.org/I192327786 |
| authorships[1].affiliations[0].raw_affiliation_string | Second Affiliated Hospital, Heilongjiang University of Chinese Medicine, Harbin, 150000, Heilongjiang, China. |
| authorships[1].institutions[0].id | https://openalex.org/I192327786 |
| authorships[1].institutions[0].ror | https://ror.org/05x1ptx12 |
| authorships[1].institutions[0].type | education |
| authorships[1].institutions[0].lineage | https://openalex.org/I192327786 |
| authorships[1].institutions[0].country_code | CN |
| authorships[1].institutions[0].display_name | Heilongjiang University of Chinese Medicine |
| authorships[1].author_position | middle |
| authorships[1].raw_author_name | Weiwei Han |
| authorships[1].is_corresponding | False |
| authorships[1].raw_affiliation_strings | Second Affiliated Hospital, Heilongjiang University of Chinese Medicine, Harbin, 150000, Heilongjiang, China. |
| authorships[2].author.id | https://openalex.org/A5113584580 |
| authorships[2].author.orcid | |
| authorships[2].author.display_name | J.J. Luan |
| authorships[2].countries | CN |
| authorships[2].affiliations[0].institution_ids | https://openalex.org/I4210102855 |
| authorships[2].affiliations[0].raw_affiliation_string | First Affiliated Hospital, Heilongjiang University of Chinese Medicine, Harbin, 150000, Heilongjiang, China. |
| authorships[2].institutions[0].id | https://openalex.org/I4210102855 |
| authorships[2].institutions[0].ror | https://ror.org/01c0exk17 |
| authorships[2].institutions[0].type | healthcare |
| authorships[2].institutions[0].lineage | https://openalex.org/I4210102855 |
| authorships[2].institutions[0].country_code | CN |
| authorships[2].institutions[0].display_name | First Affiliated Hospital of Heilongjiang University of Chinese Medicine |
| authorships[2].author_position | middle |
| authorships[2].raw_author_name | Jinhong Luan |
| authorships[2].is_corresponding | False |
| authorships[2].raw_affiliation_strings | First Affiliated Hospital, Heilongjiang University of Chinese Medicine, Harbin, 150000, Heilongjiang, China. |
| authorships[3].author.id | https://openalex.org/A5109611307 |
| authorships[3].author.orcid | |
| authorships[3].author.display_name | Boyang Ma |
| authorships[3].countries | CN |
| authorships[3].affiliations[0].institution_ids | https://openalex.org/I4210102855 |
| authorships[3].affiliations[0].raw_affiliation_string | First Affiliated Hospital, Heilongjiang University of Chinese Medicine, Harbin, 150000, Heilongjiang, China. [email protected]. |
| authorships[3].institutions[0].id | https://openalex.org/I4210102855 |
| authorships[3].institutions[0].ror | https://ror.org/01c0exk17 |
| authorships[3].institutions[0].type | healthcare |
| authorships[3].institutions[0].lineage | https://openalex.org/I4210102855 |
| authorships[3].institutions[0].country_code | CN |
| authorships[3].institutions[0].display_name | First Affiliated Hospital of Heilongjiang University of Chinese Medicine |
| authorships[3].author_position | last |
| authorships[3].raw_author_name | Baozhu Ma |
| authorships[3].is_corresponding | False |
| authorships[3].raw_affiliation_strings | First Affiliated Hospital, Heilongjiang University of Chinese Medicine, Harbin, 150000, Heilongjiang, China. [email protected]. |
| has_content.pdf | True |
| has_content.grobid_xml | True |
| is_paratext | False |
| open_access.is_oa | True |
| open_access.oa_url | https://bmcgastroenterol.biomedcentral.com/counter/pdf/10.1186/s12876-025-04117-1 |
| open_access.oa_status | gold |
| open_access.any_repository_has_fulltext | False |
| created_date | 2025-10-10T00:00:00 |
| display_name | Prognostic value of ALBI score for all-cause mortality in metabolic associated fatty liver disease patients: a cohort study from NHANES 2003–2018 |
| has_fulltext | False |
| is_retracted | False |
| updated_date | 2025-11-06T03:46:38.306776 |
| primary_topic.id | https://openalex.org/T10351 |
| primary_topic.field.id | https://openalex.org/fields/27 |
| primary_topic.field.display_name | Medicine |
| primary_topic.score | 1.0 |
| primary_topic.domain.id | https://openalex.org/domains/4 |
| primary_topic.domain.display_name | Health Sciences |
| primary_topic.subfield.id | https://openalex.org/subfields/2713 |
| primary_topic.subfield.display_name | Epidemiology |
| primary_topic.display_name | Liver Disease Diagnosis and Treatment |
| related_works | https://openalex.org/W2051786653, https://openalex.org/W3000094221, https://openalex.org/W2968051816, https://openalex.org/W2362961602, https://openalex.org/W2617159282, https://openalex.org/W2183539600, https://openalex.org/W2161883681, https://openalex.org/W3157593006, https://openalex.org/W1887541932, https://openalex.org/W1606496894 |
| cited_by_count | 0 |
| locations_count | 4 |
| best_oa_location.id | doi:10.1186/s12876-025-04117-1 |
| best_oa_location.is_oa | True |
| best_oa_location.source.id | https://openalex.org/S180811554 |
| best_oa_location.source.issn | 1471-230X |
| best_oa_location.source.type | journal |
| best_oa_location.source.is_oa | True |
| best_oa_location.source.issn_l | 1471-230X |
| best_oa_location.source.is_core | True |
| best_oa_location.source.is_in_doaj | True |
| best_oa_location.source.display_name | BMC Gastroenterology |
| best_oa_location.source.host_organization | https://openalex.org/P4310320256 |
| best_oa_location.source.host_organization_name | BioMed Central |
| best_oa_location.source.host_organization_lineage | https://openalex.org/P4310320256 |
| best_oa_location.license | cc-by-nc-nd |
| best_oa_location.pdf_url | https://bmcgastroenterol.biomedcentral.com/counter/pdf/10.1186/s12876-025-04117-1 |
| best_oa_location.version | publishedVersion |
| best_oa_location.raw_type | journal-article |
| best_oa_location.license_id | https://openalex.org/licenses/cc-by-nc-nd |
| best_oa_location.is_accepted | True |
| best_oa_location.is_published | True |
| best_oa_location.raw_source_name | BMC Gastroenterology |
| best_oa_location.landing_page_url | https://doi.org/10.1186/s12876-025-04117-1 |
| primary_location.id | doi:10.1186/s12876-025-04117-1 |
| primary_location.is_oa | True |
| primary_location.source.id | https://openalex.org/S180811554 |
| primary_location.source.issn | 1471-230X |
| primary_location.source.type | journal |
| primary_location.source.is_oa | True |
| primary_location.source.issn_l | 1471-230X |
| primary_location.source.is_core | True |
| primary_location.source.is_in_doaj | True |
| primary_location.source.display_name | BMC Gastroenterology |
| primary_location.source.host_organization | https://openalex.org/P4310320256 |
| primary_location.source.host_organization_name | BioMed Central |
| primary_location.source.host_organization_lineage | https://openalex.org/P4310320256 |
| primary_location.license | cc-by-nc-nd |
| primary_location.pdf_url | https://bmcgastroenterol.biomedcentral.com/counter/pdf/10.1186/s12876-025-04117-1 |
| primary_location.version | publishedVersion |
| primary_location.raw_type | journal-article |
| primary_location.license_id | https://openalex.org/licenses/cc-by-nc-nd |
| primary_location.is_accepted | True |
| primary_location.is_published | True |
| primary_location.raw_source_name | BMC Gastroenterology |
| primary_location.landing_page_url | https://doi.org/10.1186/s12876-025-04117-1 |
| publication_date | 2025-08-07 |
| publication_year | 2025 |
| referenced_works | https://openalex.org/W4401208791, https://openalex.org/W4383904813, https://openalex.org/W3105145706, https://openalex.org/W2987555034, https://openalex.org/W2990346698, https://openalex.org/W3134417439, https://openalex.org/W4365505095, https://openalex.org/W4387893127, https://openalex.org/W4392661141, https://openalex.org/W4406536723, https://openalex.org/W3015579983, https://openalex.org/W4381681857, https://openalex.org/W3110333352, https://openalex.org/W4293065913, https://openalex.org/W4392461762, https://openalex.org/W4395028867, https://openalex.org/W4292405063, https://openalex.org/W2192368460, https://openalex.org/W4392907803, https://openalex.org/W2784619339, https://openalex.org/W304386099, https://openalex.org/W2119190881, https://openalex.org/W4200506283, https://openalex.org/W2966059605, https://openalex.org/W3012412780, https://openalex.org/W4323307162, https://openalex.org/W2328641557, https://openalex.org/W4294862460, https://openalex.org/W4399661217, https://openalex.org/W4389159290, https://openalex.org/W2964628031, https://openalex.org/W4407485083, https://openalex.org/W2591717879, https://openalex.org/W4310463081 |
| referenced_works_count | 34 |
| abstract_inverted_index.& | 2 |
| abstract_inverted_index.< | 130, 135, 248, 318 |
| abstract_inverted_index.= | 298, 312 |
| abstract_inverted_index.a | 11, 114, 151, 220, 235, 278, 357 |
| abstract_inverted_index.p | 317 |
| abstract_inverted_index.(p | 247 |
| abstract_inverted_index.In | 207 |
| abstract_inverted_index.an | 239, 293, 372 |
| abstract_inverted_index.at | 296, 367 |
| abstract_inverted_index.in | 28, 39, 62, 113, 190, 272, 363, 395, 405 |
| abstract_inverted_index.is | 10 |
| abstract_inverted_index.of | 116, 154, 211, 223, 242, 282, 326, 360, 374, 384 |
| abstract_inverted_index.on | 78 |
| abstract_inverted_index.to | 52, 67, 103, 185, 199, 387 |
| abstract_inverted_index.we | 95, 180 |
| abstract_inverted_index.(HR | 311 |
| abstract_inverted_index.1-, | 332 |
| abstract_inverted_index.2-, | 333 |
| abstract_inverted_index.30, | 156 |
| abstract_inverted_index.8.5 | 224 |
| abstract_inverted_index.95% | 286, 314 |
| abstract_inverted_index.AUC | 324, 373 |
| abstract_inverted_index.CI: | 287, 315 |
| abstract_inverted_index.Cox | 99, 176, 302 |
| abstract_inverted_index.Our | 350 |
| abstract_inverted_index.Q3: | 137 |
| abstract_inverted_index.ROC | 320 |
| abstract_inverted_index.The | 250 |
| abstract_inverted_index.and | 36, 59, 66, 85, 93, 110, 124, 169, 194, 265, 329, 334, 346 |
| abstract_inverted_index.any | 245 |
| abstract_inverted_index.are | 356 |
| abstract_inverted_index.for | 171, 228, 254, 331, 376 |
| abstract_inverted_index.its | 33, 69 |
| abstract_inverted_index.the | 21, 54, 81, 105, 144, 191, 382 |
| abstract_inverted_index.use | 394 |
| abstract_inverted_index.was | 141, 275 |
| abstract_inverted_index.≤ | 133 |
| abstract_inverted_index.≥ | 138, 155, 369 |
| abstract_inverted_index.(HR) | 253 |
| abstract_inverted_index.(HR: | 284 |
| abstract_inverted_index.(Q1: | 128 |
| abstract_inverted_index.1.00 | 261 |
| abstract_inverted_index.1.32 | 263 |
| abstract_inverted_index.1.74 | 266 |
| abstract_inverted_index.193% | 279 |
| abstract_inverted_index.2003 | 92 |
| abstract_inverted_index.ALBI | 57, 108, 120, 129, 134, 204, 232, 257, 273, 297, 354, 368, 385 |
| abstract_inverted_index.Each | 269 |
| abstract_inverted_index.This | 49 |
| abstract_inverted_index.U.S. | 145 |
| abstract_inverted_index.aims | 3, 51 |
| abstract_inverted_index.data | 79 |
| abstract_inverted_index.from | 80, 244 |
| abstract_inverted_index.into | 126 |
| abstract_inverted_index.risk | 241, 281, 305 |
| abstract_inverted_index.role | 35 |
| abstract_inverted_index.that | 353 |
| abstract_inverted_index.this | 208, 309 |
| abstract_inverted_index.used | 195 |
| abstract_inverted_index.were | 122, 260 |
| abstract_inverted_index.with | 16, 64, 150, 238, 277, 338, 371 |
| abstract_inverted_index.-2.96 | 132 |
| abstract_inverted_index.0.652 | 330 |
| abstract_inverted_index.0.715 | 375 |
| abstract_inverted_index.1,093 | 215 |
| abstract_inverted_index.2.93, | 285 |
| abstract_inverted_index.2018, | 94 |
| abstract_inverted_index.4.86, | 313 |
| abstract_inverted_index.5,666 | 117, 212 |
| abstract_inverted_index.Fatty | 6, 146 |
| abstract_inverted_index.Index | 148 |
| abstract_inverted_index.Liver | 7, 147 |
| abstract_inverted_index.MAFLD | 40, 65, 118, 140, 213, 364 |
| abstract_inverted_index.These | 379 |
| abstract_inverted_index.While | 20 |
| abstract_inverted_index.above | 308 |
| abstract_inverted_index.cause | 246 |
| abstract_inverted_index.curve | 321 |
| abstract_inverted_index.data. | 75 |
| abstract_inverted_index.death | 243, 283 |
| abstract_inverted_index.liver | 14, 31, 161 |
| abstract_inverted_index.other | 29, 159 |
| abstract_inverted_index.point | 295 |
| abstract_inverted_index.score | 24, 153, 274 |
| abstract_inverted_index.study | 50, 210, 351 |
| abstract_inverted_index.their | 393 |
| abstract_inverted_index.these | 403 |
| abstract_inverted_index.using | 72, 143, 174, 300 |
| abstract_inverted_index.while | 157 |
| abstract_inverted_index.(ALBI) | 23 |
| abstract_inverted_index.-2.69, | 299, 370 |
| abstract_inverted_index.-2.70; | 136 |
| abstract_inverted_index.-2.96; | 131 |
| abstract_inverted_index.0.646, | 328 |
| abstract_inverted_index.0.715, | 327 |
| abstract_inverted_index.1-unit | 270 |
| abstract_inverted_index.1-year | 377 |
| abstract_inverted_index.3-year | 335 |
| abstract_inverted_index.Future | 399 |
| abstract_inverted_index.Health | 84 |
| abstract_inverted_index.NHANES | 74, 166 |
| abstract_inverted_index.Survey | 88 |
| abstract_inverted_index.across | 203, 256 |
| abstract_inverted_index.actual | 347 |
| abstract_inverted_index.assess | 104 |
| abstract_inverted_index.cohort | 115, 209 |
| abstract_inverted_index.curves | 340 |
| abstract_inverted_index.cutoff | 152 |
| abstract_inverted_index.during | 219 |
| abstract_inverted_index.early, | 391 |
| abstract_inverted_index.effect | 183, 290 |
| abstract_inverted_index.hazard | 251 |
| abstract_inverted_index.higher | 280 |
| abstract_inverted_index.median | 221 |
| abstract_inverted_index.points | 189 |
| abstract_inverted_index.ratios | 252 |
| abstract_inverted_index.remain | 46 |
| abstract_inverted_index.scores | 58, 109, 121, 233, 355, 386 |
| abstract_inverted_index.severe | 17 |
| abstract_inverted_index.should | 401 |
| abstract_inverted_index.showed | 323 |
| abstract_inverted_index.strong | 342 |
| abstract_inverted_index.values | 325 |
| abstract_inverted_index.years. | 225 |
| abstract_inverted_index.(MAFLD) | 9 |
| abstract_inverted_index.(Q1-Q3) | 259 |
| abstract_inverted_index.-2.70). | 139 |
| abstract_inverted_index.0.001). | 249 |
| abstract_inverted_index.Disease | 8 |
| abstract_inverted_index.Drawing | 77 |
| abstract_inverted_index.Methods | 76 |
| abstract_inverted_index.Results | 206 |
| abstract_inverted_index.between | 56, 91, 107, 344 |
| abstract_inverted_index.chronic | 13, 30, 160 |
| abstract_inverted_index.diverse | 406 |
| abstract_inverted_index.hazards | 101 |
| abstract_inverted_index.models. | 178 |
| abstract_inverted_index.results | 404 |
| abstract_inverted_index.sharply | 307 |
| abstract_inverted_index.tertile | 127, 258 |
| abstract_inverted_index.utility | 27 |
| abstract_inverted_index.weights | 168 |
| abstract_inverted_index.(19.29%) | 216 |
| abstract_inverted_index.(NHANES) | 89 |
| abstract_inverted_index.(US-FLI) | 149 |
| abstract_inverted_index.0.0001). | 319 |
| abstract_inverted_index.Abstract | 0 |
| abstract_inverted_index.National | 83 |
| abstract_inverted_index.adjusted | 170 |
| abstract_inverted_index.analyses | 164 |
| abstract_inverted_index.analysis | 184, 198, 291, 322 |
| abstract_inverted_index.clinical | 396 |
| abstract_inverted_index.disorder | 15 |
| abstract_inverted_index.elevated | 231 |
| abstract_inverted_index.employed | 96 |
| abstract_inverted_index.evaluate | 68 |
| abstract_inverted_index.factors, | 230 |
| abstract_inverted_index.findings | 380 |
| abstract_inverted_index.identify | 186, 388 |
| abstract_inverted_index.increase | 271 |
| abstract_inverted_index.moderate | 358 |
| abstract_inverted_index.patients | 390 |
| abstract_inverted_index.research | 400 |
| abstract_inverted_index.sampling | 167 |
| abstract_inverted_index.specific | 34 |
| abstract_inverted_index.survival | 197, 201 |
| abstract_inverted_index.validate | 402 |
| abstract_inverted_index.weighted | 97 |
| abstract_inverted_index.Following | 226 |
| abstract_inverted_index.Metabolic | 4 |
| abstract_inverted_index.Nutrition | 86 |
| abstract_inverted_index.Threshold | 289 |
| abstract_inverted_index.agreement | 343 |
| abstract_inverted_index.all-cause | 44, 60, 111, 361 |
| abstract_inverted_index.conducted | 90, 181 |
| abstract_inverted_index.diagnosed | 142 |
| abstract_inverted_index.diseases, | 32 |
| abstract_inverted_index.diseases. | 162 |
| abstract_inverted_index.excluding | 158 |
| abstract_inverted_index.follow-up | 222 |
| abstract_inverted_index.high-risk | 389 |
| abstract_inverted_index.highlight | 381 |
| abstract_inverted_index.increased | 240, 306 |
| abstract_inverted_index.mortality | 61, 112, 218, 255, 304, 362 |
| abstract_inverted_index.outcomes. | 19 |
| abstract_inverted_index.patients, | 41, 214, 365 |
| abstract_inverted_index.patients. | 119 |
| abstract_inverted_index.piecewise | 301 |
| abstract_inverted_index.potential | 18, 71, 172, 187, 383 |
| abstract_inverted_index.predicted | 345 |
| abstract_inverted_index.predictor | 359 |
| abstract_inverted_index.prevalent | 12 |
| abstract_inverted_index.regarding | 43 |
| abstract_inverted_index.tertiles. | 205 |
| abstract_inverted_index.threshold | 182, 310 |
| abstract_inverted_index.visualize | 200 |
| abstract_inverted_index.Associated | 5 |
| abstract_inverted_index.Background | 1 |
| abstract_inverted_index.Conclusion | 349 |
| abstract_inverted_index.adjustment | 227 |
| abstract_inverted_index.associated | 276 |
| abstract_inverted_index.calculated | 123 |
| abstract_inverted_index.identified | 292 |
| abstract_inverted_index.indicating | 341 |
| abstract_inverted_index.inflection | 188, 294 |
| abstract_inverted_index.mortality, | 45, 336 |
| abstract_inverted_index.mortality. | 378 |
| abstract_inverted_index.predictive | 37 |
| abstract_inverted_index.prognostic | 26, 70, 397 |
| abstract_inverted_index.regression | 102, 177 |
| abstract_inverted_index.supporting | 392 |
| abstract_inverted_index.Examination | 87 |
| abstract_inverted_index.Statistical | 163 |
| abstract_inverted_index.association | 55 |
| abstract_inverted_index.calibration | 339 |
| abstract_inverted_index.categorized | 125 |
| abstract_inverted_index.confounders | 173 |
| abstract_inverted_index.confounding | 229 |
| abstract_inverted_index.correlation | 237 |
| abstract_inverted_index.differences | 202 |
| abstract_inverted_index.experienced | 217 |
| abstract_inverted_index.individuals | 63 |
| abstract_inverted_index.investigate | 53 |
| abstract_inverted_index.large-scale | 73 |
| abstract_inverted_index.performance | 38 |
| abstract_inverted_index.regression, | 303 |
| abstract_inverted_index.significant | 236 |
| abstract_inverted_index.understood. | 48 |
| abstract_inverted_index.(reference), | 262 |
| abstract_inverted_index.3.32–7.11, | 316 |
| abstract_inverted_index.Kaplan-Meier | 196 |
| abstract_inverted_index.assessments. | 398 |
| abstract_inverted_index.demonstrated | 234 |
| abstract_inverted_index.demonstrates | 25, 352 |
| abstract_inverted_index.incompletely | 47 |
| abstract_inverted_index.incorporated | 165 |
| abstract_inverted_index.particularly | 42, 366 |
| abstract_inverted_index.populations. | 407 |
| abstract_inverted_index.proportional | 100 |
| abstract_inverted_index.relationship | 106, 193 |
| abstract_inverted_index.2.02–4.24). | 288 |
| abstract_inverted_index.Additionally, | 179 |
| abstract_inverted_index.multivariable | 98, 175 |
| abstract_inverted_index.respectively, | 337 |
| abstract_inverted_index.respectively. | 268 |
| abstract_inverted_index.(1.05–1.65), | 264 |
| abstract_inverted_index.(1.42–2.12), | 267 |
| abstract_inverted_index.ALBI-mortality | 192 |
| abstract_inverted_index.probabilities. | 348 |
| abstract_inverted_index.population-based | 82 |
| abstract_inverted_index.albumin-bilirubin | 22 |
| cited_by_percentile_year | |
| countries_distinct_count | 1 |
| institutions_distinct_count | 4 |
| sustainable_development_goals[0].id | https://metadata.un.org/sdg/3 |
| sustainable_development_goals[0].score | 0.6600000262260437 |
| sustainable_development_goals[0].display_name | Good health and well-being |
| citation_normalized_percentile.value | 0.4441276 |
| citation_normalized_percentile.is_in_top_1_percent | False |
| citation_normalized_percentile.is_in_top_10_percent | False |